17 November 2014
A new production line has opened in Moscow’s Strogino Technopark to synthesize innovation drugs, the website of Moscow’s TVTs TV channel reported.
According to the website, the new Russian drugs are “superior in a range of parameters to German analogs” and are manufactured nowhere else in Russia.
The drugs reportedly help improve cerebral blood circulation and prevent depressions. They are effective in preventing strokes, too, the source said.
The new drugs are administered to the mucous membranes of a patient’s nasal cavity and are said to be able to quickly spread across organs and tissues, reaching a damaged area in the brain and preventing the death of cells.
Starting with a capacity of 600,000 vials a year, the new site is expected to boost production sevenfold “very soon” to as many as four million.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
In 2024, salaries of Russian medical workers in the ambulance service increased by 12-14%
17 January 2025
WHO approves Russian Flu-M vaccine for global use
17 January 2025
WHO approves Russian Flu-M vaccine for global use
16 January 2025
Could novel gel therapeutic set new standard of care in oncology?
16 January 2025